Search

Solution structure of oxidized and amidated human IAPP (1-37), the diabetes II peptide.
Authors
Rodriguez Camargo, D.C., Tripsianes, K., Reif, B.
Assembly
Islet amyloid polypeptide
Entity
1. Islet amyloid polypeptide (polymer), 37 monomers, 3905.292 Da Detail

KCNTATCATQ RLANFLVHSS NNFGAILSST NVGSNTX


Formula weight
3905.292 Da
Source organism
Homo sapiens
Exptl. method
solution NMR
Refine. method
molecular dynamics
Data set
assigned_chemical_shifts
Chem. Shift Complete
Sequence coverage: 97.3 %, Completeness: 74.4 %, Completeness (bb): 71.3 % Detail

Polymer type: polypeptide(L)

Total1H13C15N
All74.4 % (282 of 379)97.4 % (186 of 191)38.6 % (56 of 145)93.0 % (40 of 43)
Backbone71.3 % (154 of 216)98.6 % (73 of 74)43.4 % (46 of 106)97.2 % (35 of 36)
Sidechain76.1 % (150 of 197)96.6 % (113 of 117)43.8 % (32 of 73)71.4 % (5 of 7)
Aromatic41.7 % (10 of 24)83.3 % (10 of 12) 0.0 % (0 of 12)
Methyl66.7 % (28 of 42)100.0 % (21 of 21)33.3 % (7 of 21)

1. entity 1

KCNTATCATQ RLANFLVHSS NNFGAILSST NVGSNTX

Sample

Solvent system 90% H2O/10% D2O, Pressure 1 atm, Temperature 278 K, pH 5.3, Details 150 uM [U-99% 13C; U-99% 15N] Islet Amyloid Polypeptide (IAPP or Amylin), 90% H2O/10% D2O


#NameIsotope labelingTypeConcentration
1Islet Amyloid Polypeptide (IAPP or Amylin)[U-99% 13C; U-99% 15N]150 uM

Protein Blocks Logo
Calculated from 20 models in PDB: 5MGQ, Strand ID: A Detail


Release date
2017-03-19
Citation
The redox environment triggers conformational changes and aggregation of hIAPP in Type II Diabetes
Rodriguez Camargo, D.C., Tripsianes, K., Buday, K., Franko, A., Gobl, C., Hartlmuller, C., Sarkar, R., Aichler, M., Mettenleiter, G., Schulz, M., Boddrich, A., Erck, C., Martens, H., Walch, A.K., Madl, T., Wanker, E.E., Conrad, M., de Angelis, M.H., Reif, B.
Sci. Rep. (2017), 7, 44041-44041, PubMed 28287098 , DOI 10.1038/srep44041 ,
Related entities 1. Islet amyloid polypeptide, : 9 : 7 entities Detail
Experiments performed 6 experiments Detail
NMR combined restraints 4 contents Detail
Keywords Recombinant human IAPP, Type II Diabetes, protein fibril